3/21
06:31 am
gsk
GSK (GSK) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
Low
Report
GSK (GSK) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
3/13
11:44 am
gsk
GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
Low
Report
GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
2/23
01:13 pm
gsk
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
Low
Report
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
2/20
01:01 pm
gsk
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
2/18
08:00 am
gsk
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
Low
Report
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
2/9
02:11 pm
gsk
GSK (NYSE:GSK) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
GSK (NYSE:GSK) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
2/9
09:12 am
gsk
GSK (NYSE:GSK) had its "hold" rating reaffirmed by analysts at TD Cowen.
Low
Report
GSK (NYSE:GSK) had its "hold" rating reaffirmed by analysts at TD Cowen.